CIK 0001607678 · Large accelerated filer
Viking Therapeutics, Inc.
Sign in to watch- Ticker
- VKTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 461073877
- Phone
- 858-704-4660
- Business address
- 9920 PACIFIC HEIGHTS BLVD, SUITE 500, SAN DIEGO, CA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-01-04 | MORNEAU MICHAEL VP, Finance and Administration | Shares withheld for taxes | −2,739 | $5.80 | $16K | 117,747 |
| 2021-01-04 | MORNEAU MICHAEL VP, Finance and Administration | Grant or award · Stock Option (Right to Buy) | +33,000 | 33,000 | ||
| 2021-01-04 | Lian Brian President & CEO | Grant or award | +164,000 | 1,876,432 | ||
| 2021-01-04 | Lian Brian President & CEO | Grant or award | +40,333 | 1,916,765 | ||
| 2021-01-04 | Lian Brian President & CEO | Shares withheld for taxes | −16,973 | $5.80 | $98K | 1,899,792 |
| 2021-01-04 | Lian Brian President & CEO | Grant or award · Stock Option (Right to Buy) | +369,000 | 369,000 | ||
| 2021-01-04 | ZANTE GREG Chief Financial Officer | Grant or award | +64,667 | 86,563 | ||
| 2021-01-04 | ZANTE GREG Chief Financial Officer | Grant or award | +6,783 | 93,346 | ||
| 2021-01-04 | ZANTE GREG Chief Financial Officer | Shares withheld for taxes | −2,787 | $5.80 | $16K | 90,559 |
| 2021-01-04 | ZANTE GREG Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +78,000 | 78,000 | ||
| 2021-01-04 | Mancini Marianna Chief Operating Officer | Grant or award | +73,000 | 167,655 | ||
| 2021-01-04 | Mancini Marianna Chief Operating Officer | Grant or award | +6,750 | 174,405 | ||
| 2021-01-04 | Mancini Marianna Chief Operating Officer | Shares withheld for taxes | −2,773 | $5.80 | $16K | 171,632 |
| 2021-01-04 | Mancini Marianna Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +90,000 | 90,000 | ||
| 2021-01-03 | Lian Brian President & CEO | Shares withheld for taxes | −31,545 | $5.63 | $178K | 1,712,432 |
| 2020-09-15 | MORNEAU MICHAEL VP, Finance and Administration | Grant or award | +4,500 | 99,430 | ||
| 2020-09-15 | MORNEAU MICHAEL VP, Finance and Administration | Shares withheld for taxes | −1,557 | $6.25 | $10K | 97,873 |
| 2020-09-15 | Lian Brian President & CEO | Grant or award | +55,500 | 1,761,555 | ||
| 2020-09-15 | Lian Brian President & CEO | Shares withheld for taxes | −19,192 | $6.25 | $120K | 1,742,363 |
| 2020-08-26 | LIGAND PHARMACEUTICALS INC 10% owner | Sale | −148,700 | $8.11 | $1.2M | 5,819,383 |
Page 21 of 27 · 528 trades